By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Magellan Biosciences and Miacom Diagnostics announced on Monday a partnership to bring Miacom's molecular tests to the US and Canada.

The combined offering covered by the agreement includes Magellan's Trek-brand VersaTrek microbial detection system, Miacom's lucesco IVD kits for the identification of bacteria and fungi/yeast from blood cultures, and Magellan's Trek Sensititre susceptibility-testing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.